Skip to content

Drug discovery team

Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets.

Our Drug Discovery Institute couples the biological expertise of international collaborators with innovative in-house drug discovery expertise. Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets. We then establish assays to screen compound libraries for hits against these targets and improve hits into potent and selective lead compounds. This provides the basis for the development of the next generation of medicines to treat neurodegeneration.

Biology
Core Disciplines: Neurobiology, Pharmacology, Screening
Head of Biology: Paul Whiting (interim)
Scientists: Sarah Jolly
Lorenza Magno
Emma Armstrong
Fiona Jeganathan
Kathryn Costelloe
Dawn Lau
Leela Phadke
Stefano Benvegnu
Susannah Baird
Chandni Patel
Lucy Granat
Carmen Navarron
Satinder Samra
Audrey Colomba
Daniel Bull (PhD student)

 

Chemistry
Core Disciplines: Medicinal & synthetic chemistry, Chemical biology, Computational chemistry
Head of Chemistry: Paul Fish
Scientists: Fredrik Svensson